International Journal of Ophthalmic PathologyISSN: 2324-8599

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Editorial,  Int J Ophthalmic Pathol Vol: 13 Issue: 4

Optic Nerve Disorders: Pathophysiology, Clinical Features and Management

Dr. Samuel Osei*

Dept. of Neuroscience, Accra Biomedical University, Ghana

*Corresponding Author:
Dr. Samuel Osei
Dept. of Neuroscience, Accra Biomedical University, Ghana
E-mail: s.osei@abu.edu.gh

Received: 01-Aug-2025, Manuscript No. iopj-26-182532; Editor assigned: 4-Aug-2025, Pre-QC No. iopj-26-182532 (PQ); Reviewed: 19-Aug-2025, iopj-26-182532; Revised: 26- Aug-2025, Manuscript No. iopj-26-182532 (R); Published: 30-Aug-2025, DOI: 10.4172/2324-8599.1000065

Citation: Samuel O (2025) Optic Nerve Disorders: Pathophysiology, Clinical Features and Management. Int J Ophthalmic Pathol 13: 065

Introduction

The optic nerve is a critical component of the visual system, transmitting visual information from the retina to the brain. Disorders of the optic nerve can lead to partial or complete vision loss, depending on the severity and location of the damage. These conditions encompass a wide range of etiologies, including inflammatory, ischemic, hereditary, compressive, and traumatic causes. Early recognition and accurate diagnosis of optic nerve disorders are essential for preventing irreversible visual impairment and guiding appropriate treatment [1,2].

Discussion

Optic nerve disorders can be broadly classified based on their underlying pathophysiology. Optic neuritis is an inflammatory condition most commonly associated with demyelinating diseases such as multiple sclerosis. It presents with sudden, often painful vision loss, color vision deficits, and visual field defects. Histopathologically, optic neuritis is characterized by demyelination and inflammatory cell infiltration of the optic nerve. Early treatment with corticosteroids can accelerate recovery, though some patients may experience persistent deficits [3,4].

Ischemic optic neuropathy occurs due to inadequate blood flow to the optic nerve, leading to sudden, painless vision loss. It is categorized as arteritic or non-arteritic. Arteritic ischemic optic neuropathy, often associated with giant cell arteritis, can result in severe and permanent vision loss if not promptly treated with systemic corticosteroids. Non-arteritic forms are usually linked to vascular risk factors such as hypertension, diabetes, and atherosclerosis.

Hereditary optic neuropathies, including Leberâ??s hereditary optic neuropathy, are caused by mitochondrial DNA mutations and typically present with subacute, bilateral central vision loss in young adults. These conditions underscore the role of genetic factors in optic nerve vulnerability [5].

Compressive lesions, such as tumors, aneurysms, or orbital masses, can exert pressure on the optic nerve, leading to progressive visual loss and optic disc changes. Traumatic optic neuropathy, resulting from direct or indirect injury to the optic nerve, may cause immediate or delayed vision loss depending on the mechanism of injury.

Diagnosis involves a combination of clinical assessment, visual field testing, fundoscopic examination, optical coherence tomography, and neuroimaging. Management strategies vary according to etiology and may include corticosteroids, immunosuppressive therapy, surgical decompression, or supportive care to optimize visual function.

Conclusion

Optic nerve disorders are diverse conditions with potentially profound effects on vision. Early detection, accurate etiological identification, and timely intervention are crucial to prevent irreversible damage. Advances in imaging, neuro-ophthalmology, and molecular diagnostics continue to enhance understanding, diagnosis, and treatment, offering better visual outcomes and quality of life for affected patients.

References

  1. Pathania A (2020) Traditional herbs Catharanthus roseus used as a anti-cancer- A Review 7:1019.

    Google Scholar

  2. Ingalwad P, Veer V, Bhosale A (2020) Overview on a Vinca Alkaloid & Its Medicinal, Therapeutic Properties. IJTSRD 4:846-49.

    Google Scholar

  3. Aziz S, Saha K, Sultana N, Ahmed S, Mansur AA, et al. (2014) Phytochemical and elemental screening on leaves and flower of Vinca rosea: An important 8, medicinal plant of Bangladesh. Int J Chem Sci 12:1328-36.

    Indexed at, Google Scholar, Crossref

  4. NVAC, Rajput M Chauhan (2011) Evaluation of Antidiarrheal Activity of Aerial Parts of Vinca Major In Experimental Animals. Middle-East Journal of Scientific Research 784-788.

    Indexed at, Google Scholar, Crossref

  5. Pillay PP, Nair CPM, Santi Kumari TN (1959) Lochnera rosea as a potential source of hypotensive and other remedies. Bulletin of Research Institute of the University of Kerala 1: 51-54.

    Indexed at, Google Scholar

international publisher, scitechnol, subscription journals, subscription, international, publisher, science

Track Your Manuscript

Awards Nomination